Yield10 Bioscience Company Description
Yield10 Bioscience, Inc. operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States.
Its products include Camelina oil for production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD), and sustainable aviation fuel (SAF).
The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017.
Yield10 Bioscience, Inc. was incorporated in 1992 and is headquartered in Woburn, Massachusetts. On December 6, 2024, Yield10 Bioscience, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
| Country | United States |
| Founded | 1992 |
| Industry | Agricultural Inputs |
| Sector | Materials |
| Employees | 29 |
| CEO | Oliver Peoples |
Contact Details
Address: 19 Presidential Way Woburn, Delaware 01801 United States | |
| Phone | 617 583 1700 |
| Website | yield10bio.com |
Stock Details
| Ticker Symbol | YTENQ |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| SIC Code | 8731 |
Key Executives
| Name | Position |
|---|---|
| Dr. Oliver P. Peoples Ph.D. | Co-Founder, President, Chief Executive Officer and Director |
| Lynne H. Brum | Vice President of Planning and Corporate Communications and Secretary |
| Charles B. Haaser CPA | Vice President of Finance, Chief Accounting Officer and Treasurer |